Clinical Trials Browser

Phase 2 × brivanib × Genitourinary × Clear all

NCT01253668 2021-04-13

Brivanib Metastatic Renal Cell Carcinoma

Phase 2 Terminated

Carcinoma, Renal Cell

NCT00888173 2017-12-06

Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

45 enrolled 10 charts

GenitourinaryGynecologic

Endometrial Adenocarcinoma

NCT00633789 2015-10-09

Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

Phase 2 Completed

GastrointestinalGenitourinarySarcoma

Adenocarcinoma Of Esophagus, Carcinoma, Transitional Cell, Sarcoma